| Jean-Daniel Flaysakier | |
| Birth Name: | Jean-Daniel Flajszakier |
| Birth Date: | 23 September 1951 |
| Birth Place: | Tours, France |
| Death Place: | Les Sables-d'Olonne, France |
| Education: | University of Tours Harvard University |
| Occupation: | Physician journalist |
| Employer: | France Télévisions |
Jean-Daniel Flaysakier, born Jean-Daniel Flajszakier (23 September 1951 – 7 October 2021) was a French doctor and journalist.[1] He was the health and medicine correspondent for and France 2 from 1980 to 2018.
Born as Jean-Daniel Flajszakier, he francisized his name to Flaysakier.[2] He earned a degree in medicine from the University of Tours and worked on the team which developed the first hepatitis B vaccine. He then earned a master's degree in epidemiology from Harvard University. Upon his return to France, he worked for written press, radio, and television.
From 1985 to 1991, Flaysakier was a health columnist on the Antenne 2 morning show Télématin, hosted by William Leymergie. He then became Deputy Editor-in-Chief of France 2 while simultaneously working in oncology.[3] He contributed to the popularization of medicine on television, where he worked for 33 years.[4] On 7 October 2018, he announced on his Twitter account that he would be retiring from France 2 at the end of the month.[5] He was occasionally criticized for his comments on unjustified medical acts.[6]
Flaysakier died of heart failure in Les Sables-d'Olonne on 7 October 2021 at the age of 70.[7]